SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-18-007639
Filing Date
2018-02-14
Accepted
2018-02-14 10:35:44
Documents
2
Period of Report
2018-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1705
2 POWER OF ATTORNEY leschly_poa.htm EX-24.1 5940
  Complete submission text file 0001140361-18-007639.txt   9340
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CARE CAPITAL III LLC 47 HULFISH STREET, SUITE 310 PRINCETON NJ 08542
Business Address
LESCHLY JAN (Reporting) CIK: 0001204568 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35285 | Film No.: 18608526